Abstract: A protective surface treatment in the form of a coating for steel or another metal or metal alloy capable of providing oxidation resistance in an inert gas furnace or air-containing furnace is provided. The coating is formed by a solution including at least one flux agent, such as boric acid, and at least one binder, such as polyvinylpyrrolidone (PVP), polyvinylpyrrolidone/vinyl acetate (PVP/VA), hydrooxypropylcellulose (HPC), ethylcellulose, and/or acrylics. The solution also includes at least one solvent, such as methanol or ethanol and can include various additives. The finished coating includes iron borate and provides a glassy surface.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: The present invention is directed to pyridyl derivatives which are bromodomain inhibitors, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases or conditions

Abstract: The present invention is directed to pyrazole derivatives, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy

Abstract: A method of forming polymer composites includes mixing a transition metal oxide precursor including at least one transition metal, a polymer as a binder, a solvent for the polymer, and water to form a first solution including polymer-transition metal complexes. The polymer-transition metal complexes are hydrolyzed to produce a plurality of transition metal oxide nanoparticles, wherein water is added in the mixing in a stoichiometric excess for the hydrolyzing. The solvent and residual of the water remaining after the hydrolyzing are removed. A polymer composite including the transition metal oxide nanoparticles dispersed in the polymer results after the removing, where some of the polymer is chemically conjugated to a surface of the transition metal oxide nanoparticles.

Abstract: A method of forming polymer composites having transition metal oxide nanoparticles dispersed therein includes mixing a transition metal oxide precursor including at least one transition metal, a polymer as a binder, a solvent for the polymer, and water to form a first solution including polymer-transition metal complexes. The polymer-transition metal complexes are hydrolyzed to produce a plurality of transition metal oxide nanoparticles, wherein water is added in the mixing in a stoichiometric excess for the hydrolyzing. The solvent and residual of the water remaining after the hydrolyzing are removed. A polymer composite including a plurality of transition metal oxide nanoparticles dispersed in the polymer results after the removing, where some of the polymer is chemically conjugated to a surface of the transition metal oxide nanoparticles.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: An electronics device is configured for installation in the brake light circuitry of a vehicle braking system. The electronics device is particularly configured to provide a flashing or pulsing appearance for a brake light, such as an automobile CHMSL. The pulsing is accomplished in a precise manner and that provides additional operational safety features than standard automotive brake lights. The electronics device is configured to avoid over-triggering of the pulsating lights due to multiple application of the automobile's brakes in a short time frame. The electronics device is further configured to function correctly even if the automobile is equipped with sophisticated computer systems that analyze the brake light circuitry, and is configured to avoid detection as a problem by the vehicle's diagnostic systems. At the same time, the electronics device will still allow the vehicle's diagnostic scans to detect any actual problems with the brake light system without hindrance.

Abstract: An electronics device is configured for installation in the brake light circuitry of a vehicle braking system. The electronics device is particularly configured to provide a flashing or pulsing appearance for a brake light, such as an automobile CHMSL. The pulsing is accomplished in a precise manner and that provides additional operational safety features than standard automotive brake lights. The electronics device is configured to avoid over-triggering of the pulsating lights due to multiple application of the automobile's brakes in a short time frame. The electronics device is further configured to function correctly even if the automobile is equipped with sophisticated computer systems that analyze the brake light circuitry, and is configured to avoid detection as a problem by the vehicle's diagnostic systems. At the same time, the electronics device will still allow the vehicle's diagnostic scans to detect any actual problems with the brake light system without hindrance.

Abstract: An electronics device is configured for installation in the brake light circuitry of a vehicle braking system. The electronics device is particularly configured to provide a flashing or pulsing appearance for a brake light, such as an automobile CHMSL. The pulsing is accomplished in a precise manner and that provides additional operational safety features than standard automotive brake lights. The electronics device is configured to avoid over-triggering of the pulsating lights due to multiple application of the automobile's brakes in a short time frame. The electronics device is further configured to function correctly even if the automobile is equipped with sophisticated computer systems that analyze the brake light circuitry, and is configured to avoid detection as a problem by the vehicle's diagnostic systems. At the same time, the electronics device will still allow the vehicle's diagnostic scans to detect any actual problems with the brake light system without hindrance.